Stem Point Capital LP Applied Therapeutics Inc. Transaction History
Stem Point Capital LP
- $340 Billion
- Q2 2024
A detailed history of Stem Point Capital LP transactions in Applied Therapeutics Inc. stock. As of the latest transaction made, Stem Point Capital LP holds 2,211,320 shares of APLT stock, worth $17.6 Million. This represents 3.03% of its overall portfolio holdings.
Number of Shares
2,211,320
Previous 2,017,016
9.63%
Holding current value
$17.6 Million
Previous $13.7 Billion
24.71%
% of portfolio
3.03%
Previous 3.63%
Shares
3 transactions
Others Institutions Holding APLT
# of Institutions
100Shares Held
103MCall Options Held
797KPut Options Held
80.8K-
Franklin Resources Inc San Mateo, CA10.2MShares$81.3 Million0.02% of portfolio
-
Vr Adviser, LLC New York, NY9.54MShares$76 Million4.89% of portfolio
-
Perceptive Advisors LLC New York, NY8.01MShares$63.7 Million1.08% of portfolio
-
Janus Henderson Group PLC London, X07.65MShares$60.9 Million0.02% of portfolio
-
Black Rock Inc. New York, NY6.57MShares$52.3 Million0.0% of portfolio
About Applied Therapeutics Inc.
- Ticker APLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,020,700
- Market Cap $382M
- Description
- Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...